FBInvestor
Stocks / Climb Bio Inc
Institutional Ownership

Climb Bio Inc

CUSIP 28658R106COMCLYMQ1 2026

13D / 13G Filings
30
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
50.0%
Max % of class reported
Institutional Holders
77
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

30 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Mpm Bioimpact LLC13G5.6%2.67MSEC
2Dec 15, 2025Ra Capital Management, L.P.13D/A33.0%SEC
3Oct 16, 2025Ai Eti LLC13D/ASEC
4Oct 7, 2025Ai Eti LLC13D/A5.7%SEC
5Sep 18, 2025Pontifax Vi G.P. L.P.13G7.7%5.21MSEC
6Feb 13, 2025Bml Investment Partners, L.P.13G/ASEC
7Nov 14, 2024Deep Track Capital, LP13G/A3.2%2.17MSEC
8Aug 16, 2024Ai Eti LLC13D/A7.5%5.01MSEC
9Aug 14, 2024Affinity Asset Advisors, LLC13G/A2.7%1.81MSEC
10Jul 2, 2024Deep Track Capital, LP13G5.8%3.90MSEC

20 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Climb Bio Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →